A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls

Serum lipids abnormalities are widespread among patients with chronic hepatitis C (CHC), but the impact of concomitant hepatic steatosis [steatosis, nonalcoholic steatosis (NAS)], as well as distinctions between it and nonalcoholic fatty liver disease (NAFLD) are not well established yet. The aim of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Valkov I., Ivanova R., Marinova C., Alexiev A., Antonov K., Jelev D., Ivanova R. S., Mateva L.
Formato:	article
Lenguaje:	EN
Publicado:	Sciendo 2017
Materias:	hepatitis c virus nonalcoholic fatty liver disease metabolic syndrome triglycerides low-density lipoprotein lipoprotein(a) Medicine R
Acceso en línea:	https://doaj.org/article/da757f1fbc844fa797c1175315432bf8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:da757f1fbc844fa797c1175315432bf8
record_format	dspace
spelling	oai:doaj.org-article:da757f1fbc844fa797c1175315432bf82021-12-02T19:17:53ZA Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls0324-175010.1515/amb-2017-0001https://doaj.org/article/da757f1fbc844fa797c1175315432bf82017-05-01T00:00:00Zhttps://doi.org/10.1515/amb-2017-0001https://doaj.org/toc/0324-1750Serum lipids abnormalities are widespread among patients with chronic hepatitis C (CHC), but the impact of concomitant hepatic steatosis [steatosis, nonalcoholic steatosis (NAS)], as well as distinctions between it and nonalcoholic fatty liver disease (NAFLD) are not well established yet. The aim of the study was to assess and compare the serum lipids in patients with genotype 1 CHC with and without steatosis, those with NAFLD, and healthy controls (HC). A total of 1010 subjects were included in this study: 366 CHC genotype 1 patients with steatosis (n = 227) and without steatosis (n = 139), 403 NAFLD patients, and 241 HC without fatty liver or other disease, matched for age and gender. Serum lipids, body mass index (BMI), components of metabolic syndrome (MS), and serum insulin levels were evaluated. In addition serum lipoprotein (a) [Lp(a)] levels were studied in 112 CHC and 80 NAFLD patients. The mean levels of total cholesterol, LDL-cholesterol and triglycerides (Tg) were higher and the mean levels of HDL-cholesterol were lower in all patients with steatosis (CHC and NAFLD) than in CHC cases without steatosis (p < 0.05 and p = 0.001, resp.). Higher prevalence and severity of lipid abnormalities, including Lp(a), were observed in patients with NAFLD than in those with CHC (p < 0.001). No difference was found between CHC patients without steatosis and HC. Higher prevalence and grade of glucose metabolic abnormalities were also observed in patients with NAFLD and CHC with steatosis than in cases without steatosis (p < 0.05 and p = 0.001, resp.). Lipid and glucose metabolic abnormalities in patients with CHC were dependent on steatosis. CHC with steatosis and NAFLD were associated with insulin resistant type dyslipidemia, with total cholesterol and LDL-cholesterol being generally lower in CHC.Valkov I.Ivanova R.Marinova C.Alexiev A.Antonov K.Jelev D.Ivanova R. S.Mateva L.Sciendoarticlehepatitis c virusnonalcoholic fatty liver diseasemetabolic syndrometriglycerideslow-density lipoproteinlipoprotein(a)MedicineRENActa Medica Bulgarica, Vol 44, Iss 1, Pp 5-10 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	hepatitis c virus nonalcoholic fatty liver disease metabolic syndrome triglycerides low-density lipoprotein lipoprotein(a) Medicine R
spellingShingle	hepatitis c virus nonalcoholic fatty liver disease metabolic syndrome triglycerides low-density lipoprotein lipoprotein(a) Medicine R Valkov I. Ivanova R. Marinova C. Alexiev A. Antonov K. Jelev D. Ivanova R. S. Mateva L. A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
description	Serum lipids abnormalities are widespread among patients with chronic hepatitis C (CHC), but the impact of concomitant hepatic steatosis [steatosis, nonalcoholic steatosis (NAS)], as well as distinctions between it and nonalcoholic fatty liver disease (NAFLD) are not well established yet. The aim of the study was to assess and compare the serum lipids in patients with genotype 1 CHC with and without steatosis, those with NAFLD, and healthy controls (HC). A total of 1010 subjects were included in this study: 366 CHC genotype 1 patients with steatosis (n = 227) and without steatosis (n = 139), 403 NAFLD patients, and 241 HC without fatty liver or other disease, matched for age and gender. Serum lipids, body mass index (BMI), components of metabolic syndrome (MS), and serum insulin levels were evaluated. In addition serum lipoprotein (a) [Lp(a)] levels were studied in 112 CHC and 80 NAFLD patients. The mean levels of total cholesterol, LDL-cholesterol and triglycerides (Tg) were higher and the mean levels of HDL-cholesterol were lower in all patients with steatosis (CHC and NAFLD) than in CHC cases without steatosis (p < 0.05 and p = 0.001, resp.). Higher prevalence and severity of lipid abnormalities, including Lp(a), were observed in patients with NAFLD than in those with CHC (p < 0.001). No difference was found between CHC patients without steatosis and HC. Higher prevalence and grade of glucose metabolic abnormalities were also observed in patients with NAFLD and CHC with steatosis than in cases without steatosis (p < 0.05 and p = 0.001, resp.). Lipid and glucose metabolic abnormalities in patients with CHC were dependent on steatosis. CHC with steatosis and NAFLD were associated with insulin resistant type dyslipidemia, with total cholesterol and LDL-cholesterol being generally lower in CHC.
format	article
author	Valkov I. Ivanova R. Marinova C. Alexiev A. Antonov K. Jelev D. Ivanova R. S. Mateva L.
author_facet	Valkov I. Ivanova R. Marinova C. Alexiev A. Antonov K. Jelev D. Ivanova R. S. Mateva L.
author_sort	Valkov I.
title	A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
title_short	A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
title_full	A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
title_fullStr	A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
title_full_unstemmed	A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
title_sort	comparative analysis of serum lipids in patients with chronic hepatitis c, nonalcoholic fatty liver disease and healthy controls
publisher	Sciendo
publishDate	2017
url	https://doaj.org/article/da757f1fbc844fa797c1175315432bf8
work_keys_str_mv	AT valkovi acomparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT ivanovar acomparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT marinovac acomparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT alexieva acomparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT antonovk acomparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT jelevd acomparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT ivanovars acomparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT mateval acomparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT valkovi comparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT ivanovar comparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT marinovac comparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT alexieva comparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT antonovk comparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT jelevd comparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT ivanovars comparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols AT mateval comparativeanalysisofserumlipidsinpatientswithchronichepatitiscnonalcoholicfattyliverdiseaseandhealthycontrols
_version_	1718376883963297792

A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls

Ejemplares similares